✦ LIBER ✦

A randomized multicentric study comparing alternating combination chemotherapy (VCMP/VBAP) and melphalan-prednisone in multiple myeloma

✍ Scribed by Bladé, J. ;San Miguel, J. ;Alcalá, A. ;Maldonado, J. ;García-Conde, J. ;Moro, M. J. ;Sanz Sanz, M. A. ;Alonso, C. ;Zubizarreta, A. ;Besses, C. ;Hernández Martín, J. M. ;Besalduch, J. ;Hernández Nieto, L. ;Fernández Calvo, J. ;Rubio, D. ;Mayans, J. R. ;Sanchis, J. ;Jimenez Galindo, R. ;Tortosa, J. ;Ortega, F. ;Domingo, A. ;Faura, M. V. ;Daniels, M. ;Rozman, C. ;Estapé, J.

Publisher: Springer-Verlag
Year: 1990
Weight: 457 KB
Volume: 60
Category: Article
ISSN: 1432-0584
DOI: 10.1007/bf01737844

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of Bendamustine and Prednisone

Treatment of Bendamustine and Prednisone in patients with newly diagnosed multiple myeloma results in superior complete response rate, prolonged time to treatment failure and improved quality of life compared to treatment with Melphalan and Prednisone—a randomized phase III study of the East German Study Group of Hematology and Oncology (OSHO)

✍ W. Pönisch; P. S. Mitrou; K. Merkle; M. Herold; M. Assmann; G. Wilhelm; K. Dachs 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 344 KB